• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过综合生物信息学分析鉴定透明细胞肾细胞癌中的关键基因CCL5、PLG、LOX和C3

Identification of key genes CCL5, PLG, LOX and C3 in clear cell renal cell carcinoma through integrated bioinformatics analysis.

作者信息

Xie Zhenwei, Feng Cheng, Hong Yude, Chen Libo, Li Mingyong, Deng Weiming

机构信息

Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Department of Thyroid and Galactophore Surgery, People's Hospital of Longhua, Shenzhen, China.

出版信息

Front Mol Biosci. 2025 May 6;12:1587196. doi: 10.3389/fmolb.2025.1587196. eCollection 2025.

DOI:10.3389/fmolb.2025.1587196
PMID:40396123
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12088980/
Abstract

BACKGROUND

Clear Cell Renal Cell Carcinoma (ccRCC) is a malignant tumor with high mortality and recurrence rates and the molecular mechanism of ccRCC genesis remains unclear. In this study, we identified several key genes associated with the prognosis of ccRCC by using integrated bioinformatics.

METHODS

Two ccRCC expression profiles were downloaded from Gene Expression Omnibus and one dataset was gained from The Cancer Genome Atlas The Robust Rank Aggregation method was used to analyze the three datasets to gain integrated differentially expressed genes The Gene Ontology and KEGG analysis were performed to explore the potential functions of DEGs. The Search Tool for the Retreival of Interacting Genes/Proteins (STRING) and Cytoscape software were used to construct protein-protein interaction network and module analyses to screen the hub genes. Spearman's correlation analysis was conducted to evaluate the interrelationships among the hub genes. The prognostic value was evaluated through K-M survival analysis, Cox regression analysis, and receiver operating characteristic curve analysis to determine their potential as prognostic biomarkers in ccRCC. The expression of hub genes between ccRCC and adjacent normal tissues was analyzed by RT-qPCR, Western blotting, and immunohistochemical (IHC).

RESULT

125 DEGs were identified using the limma package and RRA method, including 62 up-expressed genes and 63 down-expressed genes. GO and KEGG analysis showed some associated pathways. Spearman's correlation analysis revealed that the hub genes are not only interrelated but also closely associated with immune cell infiltration. Gene expression analysis of the hub genes based on the TCGA-KIRC cohort, along with K-M survival analysis, Cox regression, and ROC curve analysis, consistently demonstrated that CCL5, LOX, and C3 are significantly upregulated in ccRCC and are associated with poor clinical outcomes. In contrast, PLG showed opposite result. These results were further validated at the mRNA and protein levels.

CONCLUSION

Our findings indicate that CCL5, LOX, C3, and PLG are significantly associated with the progression and prognosis of ccRCC, highlighting their potential as prognostic biomarkers. These results provide a foundation for future research aimed at uncovering the underlying mechanisms and identifying potential therapeutic targets for ccRCC.

摘要

背景

透明细胞肾细胞癌(ccRCC)是一种死亡率和复发率都很高的恶性肿瘤,其发病的分子机制尚不清楚。在本研究中,我们通过整合生物信息学方法鉴定了几个与ccRCC预后相关的关键基因。

方法

从基因表达综合数据库(Gene Expression Omnibus)下载了两个ccRCC表达谱,并从癌症基因组图谱(The Cancer Genome Atlas)获得了一个数据集。使用稳健秩聚合(Robust Rank Aggregation)方法分析这三个数据集,以获得整合的差异表达基因。进行基因本体论(Gene Ontology)和京都基因与基因组百科全书(KEGG)分析,以探索差异表达基因的潜在功能。使用搜索相互作用基因/蛋白质的工具(STRING)和Cytoscape软件构建蛋白质-蛋白质相互作用网络并进行模块分析,以筛选枢纽基因。进行Spearman相关性分析,以评估枢纽基因之间的相互关系。通过K-M生存分析、Cox回归分析和受试者工作特征曲线分析评估预后价值,以确定它们作为ccRCC预后生物标志物的潜力。通过实时定量PCR(RT-qPCR)、蛋白质免疫印迹法和免疫组织化学(IHC)分析ccRCC与相邻正常组织之间枢纽基因的表达。

结果

使用limma软件包和RRA方法鉴定出125个差异表达基因,其中包括62个上调基因和63个下调基因。基因本体论和KEGG分析显示了一些相关途径。Spearman相关性分析表明,枢纽基因不仅相互关联,而且与免疫细胞浸润密切相关。基于TCGA-KIRC队列对枢纽基因进行基因表达分析,并结合K-M生存分析、Cox回归和ROC曲线分析,一致表明CCL5、LOX和C3在ccRCC中显著上调,并与不良临床结果相关。相比之下,PLG则呈现相反的结果。这些结果在mRNA和蛋白质水平上得到了进一步验证。

结论

我们的研究结果表明,CCL5、LOX、C3和PLG与ccRCC的进展和预后显著相关,突出了它们作为预后生物标志物的潜力。这些结果为未来旨在揭示潜在机制和确定ccRCC潜在治疗靶点的研究奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/165ae1f7b48d/fmolb-12-1587196-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/754dc6337af1/fmolb-12-1587196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/d06384ff0859/fmolb-12-1587196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/479339021914/fmolb-12-1587196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/02603998583f/fmolb-12-1587196-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/ea4239eeec41/fmolb-12-1587196-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/991c1c5f9688/fmolb-12-1587196-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/fb2a49101917/fmolb-12-1587196-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/165ae1f7b48d/fmolb-12-1587196-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/754dc6337af1/fmolb-12-1587196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/d06384ff0859/fmolb-12-1587196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/479339021914/fmolb-12-1587196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/02603998583f/fmolb-12-1587196-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/ea4239eeec41/fmolb-12-1587196-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/991c1c5f9688/fmolb-12-1587196-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/fb2a49101917/fmolb-12-1587196-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf8/12088980/165ae1f7b48d/fmolb-12-1587196-g008.jpg

相似文献

1
Identification of key genes CCL5, PLG, LOX and C3 in clear cell renal cell carcinoma through integrated bioinformatics analysis.通过综合生物信息学分析鉴定透明细胞肾细胞癌中的关键基因CCL5、PLG、LOX和C3
Front Mol Biosci. 2025 May 6;12:1587196. doi: 10.3389/fmolb.2025.1587196. eCollection 2025.
2
Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).C3 和 CXCR4 的生物信息学分析表明它们可能成为透明细胞肾细胞癌 (ccRCC) 的预后生物标志物。
BMC Cancer. 2021 Jul 15;21(1):814. doi: 10.1186/s12885-021-08525-w.
3
Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.通过生物信息学分析对透明细胞肾细胞癌中新型关键基因ITGAX、LAPTM5、SERPINE1进行预测与分析
PeerJ. 2021 Apr 20;9:e11272. doi: 10.7717/peerj.11272. eCollection 2021.
4
Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.鉴定CXCL10作为透明细胞肾细胞癌的预后生物标志物
Front Oncol. 2022 Feb 28;12:857619. doi: 10.3389/fonc.2022.857619. eCollection 2022.
5
Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis.肾透明细胞癌中潜在生物标志物和治疗靶点的筛选:来自生物信息学分析的证据
Front Oncol. 2022 Oct 13;12:963483. doi: 10.3389/fonc.2022.963483. eCollection 2022.
6
Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.通过综合生物信息学分析鉴定与透明细胞肾细胞癌相关的枢纽基因
Front Oncol. 2021 Sep 30;11:726655. doi: 10.3389/fonc.2021.726655. eCollection 2021.
7
Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.LYSET 功能富集分析及相关枢纽基因特征的鉴定,作为预测透明细胞肾细胞癌预后和免疫浸润状态的新型生物标志物。
J Cancer Res Clin Oncol. 2023 Dec;149(18):16905-16929. doi: 10.1007/s00432-023-05280-2. Epub 2023 Sep 23.
8
Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.用于鉴定影响透明细胞肾细胞癌发病机制的潜在关键基因的综合生物信息学分析
Oncol Lett. 2020 Aug;20(2):1573-1584. doi: 10.3892/ol.2020.11703. Epub 2020 Jun 5.
9
Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.SLC34A1 的低表达与透明细胞肾细胞癌的不良预后相关。
BMC Urol. 2023 Mar 28;23(1):45. doi: 10.1186/s12894-023-01212-x.
10
Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.鉴定 C3 和 FN1 作为与透明细胞肾细胞癌进展和预后相关的潜在生物标志物。
BMC Cancer. 2021 Oct 23;21(1):1135. doi: 10.1186/s12885-021-08818-0.

本文引用的文献

1
CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases.肿瘤微环境中癌相关成纤维细胞与巨噬细胞的相互作用决定了胃癌腹膜转移对免疫检查点阻断的反应。
Gut. 2025 Feb 6;74(3):350-363. doi: 10.1136/gutjnl-2024-333617.
2
Downregulation of chemokine (C‑C motif) ligand 5 induced by a novel 8‑hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma.新型 8-羟基喹啉衍生物(91b1)下调趋化因子(C-C 基序)配体 5 的表达抑制食管癌的侵袭性。
Int J Mol Med. 2024 Dec;54(6). doi: 10.3892/ijmm.2024.5435. Epub 2024 Oct 4.
3
Renal Cell Carcinoma: A Review.
肾细胞癌:综述。
JAMA. 2024 Sep 24;332(12):1001-1010. doi: 10.1001/jama.2024.12848.
4
Renal cell carcinoma.肾细胞癌。
Lancet. 2024 Aug 3;404(10451):476-491. doi: 10.1016/S0140-6736(24)00917-6. Epub 2024 Jul 18.
5
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
6
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.一种首创的泛赖氨酸氧化酶抑制剂可破坏基质重构,增强胰腺癌对吉西他滨的反应和生存。
Nat Cancer. 2023 Sep;4(9):1326-1344. doi: 10.1038/s43018-023-00614-y. Epub 2023 Aug 28.
7
Integrated glycoproteomic characterization of clear cell renal cell carcinoma.透明细胞肾细胞癌的综合糖蛋白质组学特征分析。
Cell Rep. 2023 May 30;42(5):112409. doi: 10.1016/j.celrep.2023.112409. Epub 2023 Apr 18.
8
Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity.通过先天免疫和适应性免疫,用表达西妥昔单抗-CCL5 融合蛋白的溶瘤病毒特异性靶向神经胶质瘤。
Nat Cancer. 2022 Nov;3(11):1318-1335. doi: 10.1038/s43018-022-00448-0. Epub 2022 Nov 10.
9
Clinicopathological and prognostic value of lysyl oxidase expression in gastric cancer: a systematic review, meta-analysis and bioinformatic analysis.胃癌中赖氨酰氧化酶表达的临床病理和预后价值:系统评价、荟萃分析和生物信息学分析。
Sci Rep. 2022 Oct 6;12(1):16786. doi: 10.1038/s41598-022-21402-1.
10
Identification and validation of roles of lysyl oxidases in the predictions of prognosis, chemotherapy and immunotherapy in glioma.赖氨酰氧化酶在胶质瘤预后、化疗及免疫治疗预测中的作用鉴定与验证
Front Pharmacol. 2022 Aug 31;13:990461. doi: 10.3389/fphar.2022.990461. eCollection 2022.